In vitro diagnostics to be valued at $141.9b by 2029 | Asian Business Review
Photo from Envato

In vitro diagnostics to be valued at $141.9b by 2029

Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics.

The in vitro diagnostics market is projected to reach $141.9b by 2029 at a compound annual growth rate of 8.4%, according to BCC Research.

The sector’s expansion is attributed to the increasing ageing population and the rise of chronic diseases, such as diabetes and heart conditions.

Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics, with demand surging post-pandemic.

Meanwhile, artificial intelligence integration is improving the accuracy and speed of disease detection, further driving market growth.

Follow the link for more news on

Join Asian Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

In vitro diagnostics to be valued at $141.9b by 2029
Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics.
Healthcare
What is holding back energy transition in APAC?
Green energy investment in Asia is around 45% of the global level in 2023.
Hong Kong’s insurance premiums reach $83b in 2024
Both long-term and general insurance sectors registered notable increases.
Insurance